Status:
UNKNOWN
Impact of Nimodipine on Sublingual Microcirculation in Patients With Hemorrhage - a Prospective Monocentric Observational Study
Lead Sponsor:
University Hospital Hradec Kralove
Conditions:
Subarachnoid Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
Nimodipine can increase Functional Capillary Density (FCD) as a parameter of the sublingual microcirculation in patients with subarachnoid hemorrhage (SAH) compared to patients without nimodipine.
Detailed Description
SAH group - in patients with SAH and documented vasospasms by digital subtraction angiography (DSA) of trans-cranial doppler imaging (TCD) of arteria cerebri media nimodipine is indicated because it i...
Eligibility Criteria
Inclusion
- adulthood
- ICU admission
- diagnosis of non-traumatic subarachnoid hemorrhage
Exclusion
- inherited coagulation disorder
- rheumatic disease
- microangiopathy
- patient of representative refusal
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04311840
Start Date
November 1 2019
End Date
December 31 2022
Last Update
September 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Hradec Kralove
Hradec Králové, Třebeš, Czechia, 50005